Showing 721 - 740 results of 11,362 for search '(((spinae OR sspinae) OR (five OR (financed OR sspined))) OR ((pinn OR (pin OR ping)) OR long))', query time: 0.24s Refine Results
  1. 721
  2. 722

    Restriction analysis and sequencing of the ITS regions and 5.8S gene of rDNA of Ganoderma isolates from infected oil palm and coconut stumps in Malaysia by Latiffah, Z., Harikrishna, K., Tan, S.G., Tan, S.H., Abdullah, F., Ho, Y.W.

    Published 2002
    “…Restriction analysis and sequencing of the ITS regions and 5.8S gene of rDNA were conducted on 53 Ganoderma isolates from infected oil palm and 15 isolates from coconut stumps to determine their relatedness. …”
    Get full text
    Article
  3. 723

    Optimizing Sustainable Concrete Strength With Laminated Waste Glass (Lwg): Insights From Waterto-Cement Ratios And Slump Values (0.35-0.5) by Mohd Roslan, Muhammad Lutfi Fitri, Mohd Zuki, Sharifah Salwa, Shahidan, Shahiron, Mohammad Azmi, Mohamad Azim

    Published 2024
    “…A series of experiments were conducted to assess the compressive strength, split tensile strength, and slump attributes of LWG concrete with w/c ratios ranging from 0.35 to 0.5 and a 15% replacement of fine aggregate with LWG. …”
    Get full text
    Article
  4. 724

    PTEN-opathies : from biological insights to evidence-based precision medicine by Yehia, Lamis, Ngeow, Joanne, Eng, Charis

    Published 2019
    Subjects: “…Phosphatidylinositol 3,4,5-Trisphosphate…”
    Get full text
    Get full text
    Journal Article
  5. 725
  6. 726
  7. 727
  8. 728
  9. 729
  10. 730
  11. 731
  12. 732
  13. 733

    Early and strong leptin reduction is predictive for long-term weight loss during high-protein, low-glycaemic meal replacement: a subanalysis of the randomised-controlled ACOORH trial by Kempf, Kerstin, Röhling, Martin, Banzer, Winfried, Braumann, Klaus-Michael, Halle, Martin, Schaller, Nina, McCarthy, H. David, Predel, Hans Georg, Schenkenberger, Isabelle, Tan, Susanne, Toplak, Hermann, Martin, Stephan, Berg, Aloys

    Published 2022
    “…Strongest weight loss was observed after 6 months (-5.9 ± 5.1 kg in females of the intervention group vs. -2.9 ± 4.9 kg in the control group ( < 0.0001); -6.8 ± 5.3 kg vs. -4.1 ± 4.4 kg ( = 0.003) in males) and in those participants with combined leptin and insulin decrease. …”
    Get full text
    Article
  14. 734

    Long-Term Associations between Disaster-Related Home Loss and Health and Well-Being of Older Survivors: Nine Years after the 2011 Great East Japan Earthquake and Tsunami by Shiba, Koichiro, Hikichi, Hiroyuki, Okuzono, Sakurako S., VanderWeele, Tyler J., Arcaya, Mariana, Daoud, Adel, Cowden, Richard G., Yazawa, Aki, Zhu, David T., Aida, Jun, Kondo, Katsunori, Kawachi, Ichiro

    Published 2024
    “…BACKGROUND: Little research has examined associations between disaster-related home loss and multiple domains of health and well-being, with extended long-term follow-up and comprehensive adjustment for pre-disaster characteristics of survivors. …”
    Get full text
    Article
  15. 735
  16. 736

    Pricing Nikkei index put warrants under fixed and floating exchange rate. by Solihin, Norman., Ryanto, Rudy.

    Published 2009
    Subjects: “…DRNTU::Business::Finance::Equity…”
    Get full text
    Thesis
  17. 737

    Environmental, social, and governance (ESG) reporting and missing (M) scores in the Industry 5.0 era: broadening firms’ and investors’ decisions to achieve sustainable development goals by Yadav, Sanjeev, Samadhiya, Ashutosh, Kumar, Anil, Luthra, Sunil, Pandey, Krishan Kumar

    Published 2024
    “…Environmental, social, and governance (ESG) factors are gradually being utilized to assess organizations' long-term success, drive capital, and inform company decision-making toward sustainable growth. …”
    Get full text
    Get full text
    Article
  18. 738
  19. 739
  20. 740

    Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial by Silk, SE, Kalinga, WF, Salkeld, J, Mtaka, IM, Ahmed, S, Milando, F, Diouf, A, Bundi, CK, Balige, N, Hassan, O, Mkindi, CG, Rwezaula, S, Athumani, T, Mswata, S, Lilolime, NS, Simon, B, Msami, H, Mohamed, M, David, DM, Mohammed, L, Nyaulingo, G, Mwalimu, B, Juma, O, Mwamlima, TG, Sasamalo, IA, Mkumbange, RP, Kamage, JJ, Barrett, JR, King, LDW, Hou, MM, Pulido, D, Carnrot, C, Lawrie, AM, Cowan, RE, Nugent, FL, Roberts, R, Cho, J-S, Long, CA, Nielsen, CM, Miura, K, Draper, SJ, Olotu, AI, Minassian, AM

    Published 2024
    “…</p> <br> <p><strong>Methods:</strong> We did a non-randomised, phase 1b, single-centre, dose-escalation, age de-escalation, first-in-human trial of RH5.1/Matrix-M in Bagamoyo, Tanzania. We recruited healthy adults (aged 18–45 years) and children (aged 5–17 months) to receive the RH5.1/Matrix-M vaccine candidate in the following three-dose regimens: 10 μg RH5.1 at 0, 1, and 2 months (Adults 10M), and the higher dose of 50 μg RH5.1 at 0 and 1 month and 10 μg RH5.1 at 6 months (delayed-fractional third dose regimen; Adults DFx). …”
    Journal article